HDAC (Histone deacetylases) are a class of enzymes that remove acetyl groups (O=C-CH3) from an ε-N-acetyl lysine amino acid on ahistone, allowing the histones to wrap the DNA more tightly.This is significant because DNA is wrapped around histones and that acetylation and de-acetylation control how DNA is expressed. In contrast to histone acetyltransferase, it acts differently. Since non-histone proteins are also among their targets, HDAC proteins are now also referred to as lysine deacetylases (KDAC) in order to better reflect their mode of action. The histone deacetylases are members of the ancient protein superfamily known as the histone deacetylase superfamily, along with the acetylpolyamine amidohydrolases and the acetoin utilization proteins.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V103728 | Martinostat | 1629052-58-9 | Martinostat is an HDAC inhibitor that can be radionuclide-labeled to allow quantitative imaging of HDAC in the central nervous system and major peripheral organs in vivo. |
![]() |
V85807 | Martinostat hydrochloride | ||
![]() |
V102688 | MD 85 | 193551-00-7 | MD 85 is a potent histone deacetylase (HDAC) inhibitor with EC50 of 5 μM. |
![]() |
V104674 | Naph-Se-TMZ | Naph-Se-TMZ is a PROTAC-like HDAC1 degrader that can reduce total HDAC activity in glioma cells and enhance the inhibitory effect of temozolomide. | |
![]() |
V101114 | NT376 | 2820208-97-5 | NT376 is a potent and selective class IIa histone deacetylase (HDAC) inhibitor with IC50 of 32 nM, similar to NT160 (IC50= 46 nM) in HT-29 cells. |
![]() |
V88673 | PARP7/HDACs-IN-1 | PARP7/HDACs-IN-1 (compound 9l) is a dual-target inhibitor targeting PARP7/HDAC with anti-tumor activity. | |
![]() |
V85810 | PB118 | ||
![]() |
V94362 | PB200 | PB200 is a HDAC6 inhibitor with IC50 of 1.97 nM. | |
![]() |
V27646 | Pivanex | 122110-53-6 | Pivanex (AN-9; AN 9; AN9; pivaloyloxymethyl butyrate; Titan) is a novel and potent histone deacetylase/HDAC inhibitor with anticancer and antiangiogenic properties. |
![]() |
V99855 | PROTAC HDAC8 Degrader-1 | PROTAC HDAC8 Degrader-1 (Compound Z16) is a potent and selective HDAC8 PROTAC degrader with a DC50 of 0.27 nM in A549 cells. | |
![]() |
V93713 | PROTAC HDAC8 Degrader-2 | PROTAC HDAC8 Degrader-2 (compound 32a) is a degrader of HDAC8 with a DC50 of 8.9 nM and a degrader of HDAC6 with a DC50 of 14.3 nM. | |
![]() |
V103367 | Purinostat | 1929583-17-4 | Purinostat is a selective HDAC I/IIb inhibitor with anti-leukemic activity. |
![]() |
V93038 | ROCK/HDAC-IN-1 | ROCK/HDAC-IN-1 (Compound 10h) is an orally available ROCK/HDAC inhibitor. | |
![]() |
V87880 | SAP15 | 1403753-45-6 | SAP15 (Synthetic anti-inflammatory peptide 15) is a synthetic anti-inflammatory peptide composed of 15 amino acids designed from human β-defensin 3. |
![]() |
V88666 | SE-7552 | 2243575-79-1 | SE-7552 is a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative and is an orally active, highly selective, non-hydroxamic acid HDAC6 inhibitor with an IC50 of 33 nM. |
![]() |
V89011 | sEH/HDAC6-IN-2 | 3009011-58-6 | sEH/HDAC6-IN-2 is a potent dual soluble epoxide hydrolase (sEH) and HDAC6 inhibitor with IC50 of 0.9 nM, 46.8 nM and 8 nM for human sEH, mouse sEH and HDAC6, respectively. |
![]() |
V88670 | SelSA | 1225038-92-5 | SelSA is an orally available, selective inhibitor of histone deacetylase 6 (HDAC6) with an IC50 of 56.9 nM. |
![]() |
V98214 | STAT3/HDAC-IN-2 | STAT3/HDAC-IN-2 (compound 18) is a dual inhibitor of STAT3 and HDAC that induces autophagy and apoptosis. | |
![]() |
V88864 | STR-V-53 | 2798954-66-0 | STR-V-53 is a HDAC inhibitor (IC50 in nM). |
![]() |
V4636 | SW-100 | 2126744-35-0 | SW-100 (SW100),a tetrahydroquinoline-based compound, is a novel, potent, brain penetrant and selectivehistone deacetylase 6 (HDAC6)inhibitor (IC50 = 2.3 nM) with neuroprotective effects. |